Open AccessLetter by Vos et al Regarding Article, “Primary Prevention With Statin Therapy in the Elderly: New Meta-Analyses From the Contemporary JUPITER and HOPE-3 Randomized Trials”
Author(s) -
Eddie Vos,
Pierre Biron,
Colin P. Rose
Publication year - 2017
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.117.029008
Subject(s) - medicine , rosuvastatin , randomized controlled trial , statin , gerontology , primary prevention , family medicine , disease
We read with interest the article by Ridker et al1 that proposes, based on 2 rosuvastatin trials, JUPITER (Justification for Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin) and HOPE-3 (Heart Outcomes Prevention Evaluation), that there would be a probable statin mortality benefit in primary prevention in the elderly.2,3 The article relies on the combined end point of nonfatal myocardial infarction, nonfatal stroke, or cardiovascular death, but without separating these …
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom